SG11202003524XA - Methods for differentiating mesenchymal stem cells - Google Patents

Methods for differentiating mesenchymal stem cells

Info

Publication number
SG11202003524XA
SG11202003524XA SG11202003524XA SG11202003524XA SG11202003524XA SG 11202003524X A SG11202003524X A SG 11202003524XA SG 11202003524X A SG11202003524X A SG 11202003524XA SG 11202003524X A SG11202003524X A SG 11202003524XA SG 11202003524X A SG11202003524X A SG 11202003524XA
Authority
SG
Singapore
Prior art keywords
methods
stem cells
mesenchymal stem
differentiating mesenchymal
differentiating
Prior art date
Application number
SG11202003524XA
Other languages
English (en)
Inventor
Sandra Pietri
Xuan Nguyen
Enrico Bastianelli
Sabrina Ena
Pierre-Yves Laruelle
Isabelle Tytgat
Original Assignee
Bone Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bone Therapeutics Sa filed Critical Bone Therapeutics Sa
Publication of SG11202003524XA publication Critical patent/SG11202003524XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
SG11202003524XA 2017-10-20 2018-09-25 Methods for differentiating mesenchymal stem cells SG11202003524XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17197605 2017-10-20
PCT/EP2018/076030 WO2019076591A1 (fr) 2017-10-20 2018-09-25 Procédés pour différencier des cellules souches mésenchymateuses

Publications (1)

Publication Number Publication Date
SG11202003524XA true SG11202003524XA (en) 2020-05-28

Family

ID=60153205

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202003524XA SG11202003524XA (en) 2017-10-20 2018-09-25 Methods for differentiating mesenchymal stem cells

Country Status (13)

Country Link
US (2) US11447749B2 (fr)
EP (1) EP3697894A1 (fr)
JP (1) JP7039711B2 (fr)
KR (1) KR102185697B1 (fr)
CN (1) CN111247240A (fr)
AU (1) AU2018351804B2 (fr)
BE (1) BE1025935A9 (fr)
BR (1) BR112020007775A2 (fr)
CA (1) CA3079439C (fr)
IL (1) IL273987B (fr)
RU (1) RU2020113411A (fr)
SG (1) SG11202003524XA (fr)
WO (1) WO2019076591A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022501053A (ja) * 2018-09-25 2022-01-06 ボーン、セラピューティクス、エスアーBone Thrapeutics Sa 間葉系幹細胞を分化させるための方法
CN113648417A (zh) * 2021-03-15 2021-11-16 中国人民解放军军事科学院军事医学研究院 Postn作为调控间充质干细胞分化能力的标志物及其应用
CN113355279A (zh) * 2021-06-07 2021-09-07 深圳市中佳生物医疗科技有限公司 一种人韧带成纤维细胞的制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4764369A (en) 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5811094A (en) 1990-11-16 1998-09-22 Osiris Therapeutics, Inc. Connective tissue regeneration using human mesenchymal stem cell preparations
US5486359A (en) 1990-11-16 1996-01-23 Osiris Therapeutics, Inc. Human mesenchymal stem cells
US5837539A (en) 1990-11-16 1998-11-17 Osiris Therapeutics, Inc. Monoclonal antibodies for human mesenchymal stem cells
US5972703A (en) 1994-08-12 1999-10-26 The Regents Of The University Of Michigan Bone precursor cells: compositions and methods
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5827740A (en) 1996-07-30 1998-10-27 Osiris Therapeutics, Inc. Adipogenic differentiation of human mesenchymal stem cells
US7635467B2 (en) * 2002-01-14 2009-12-22 The Board Of Trustees Of The University Of Illinois Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
DK1989295T3 (da) * 2006-02-16 2020-09-28 Univ Bruxelles Fremgangsmåde til osteogen differentiering af knoglemarv-stamceller (bmsc) og anvendelser deraf
WO2008129563A2 (fr) * 2007-04-23 2008-10-30 Stempeutics Research Private Limited, Cellules souches mésenchymales humaines et leur préparation
US20100278788A1 (en) 2008-01-11 2010-11-04 Bone Therapeutics, S.A. Osteogenic Differentiation Of Bone Marrow Stem Cells And Mesenchymal Stem Cells Using A Combination Of Growth Factors
CA2863795A1 (fr) * 2012-02-13 2013-08-22 Gamida-Cell Ltd. Culture de cellules souches mesenchymateuses
JP6525889B2 (ja) * 2013-01-12 2019-06-05 セスカ セラピューティクス， インコーポレイテッド 自己骨髄由来の幹細胞の迅速な注入
JP2017506511A (ja) 2014-02-14 2017-03-09 ナショナル ユニバーシティー オブ アイルランド， ゴールウェイ 無血清培地
JP6446222B2 (ja) * 2014-09-30 2018-12-26 株式会社ジーシー 軟骨分化培養液、及び軟骨組織の製造方法

Also Published As

Publication number Publication date
RU2020113411A (ru) 2021-11-22
CN111247240A (zh) 2020-06-05
BE1025935A9 (fr) 2019-11-05
JP2020537539A (ja) 2020-12-24
IL273987B (en) 2021-06-30
US20200354682A1 (en) 2020-11-12
BE1025935B1 (fr) 2019-10-18
US11447749B2 (en) 2022-09-20
EP3697894A1 (fr) 2020-08-26
BE1025935A1 (fr) 2019-08-13
BR112020007775A2 (pt) 2020-10-20
WO2019076591A1 (fr) 2019-04-25
AU2018351804A1 (en) 2020-05-14
RU2020113411A3 (fr) 2021-11-22
BE1025935B9 (fr) 2019-10-29
CA3079439A1 (fr) 2019-04-25
US20230042822A1 (en) 2023-02-09
IL273987A (en) 2020-05-31
KR102185697B1 (ko) 2020-12-03
CA3079439C (fr) 2022-08-09
KR20200063241A (ko) 2020-06-04
JP7039711B2 (ja) 2022-03-22
AU2018351804B2 (en) 2020-07-09

Similar Documents

Publication Publication Date Title
IL250340A0 (en) Growth media for the culture of pluripotent stem cells
IL250132A0 (en) A method to induce t-cell immunocytotherapy from stem cell potential
EP3384007C0 (fr) Procédés améliorés de reprogrammation de cellules non-pluripotentes en cellules souches pluripotentes
EP3199169A4 (fr) Composition contenant un mélange cellules souches mésenchymateuses - hydrogel, et procédé de production de la composition
SG11201706886PA (en) Cell culture method for mesenchymal stem cells
EP3383182C0 (fr) Procédés de production de cellules souches hématopoïétiques fonctionnelles
IL257678A (en) Methods of stem cell transplantation
IL281751A (en) Methods for inducing differentiation in mesenchymal stem cells
EP3202896A4 (fr) Procédé de culture de cellules souches pluripotentes
HK1247639A1 (zh) 培養幹細胞的培養基組合物
IL249170A0 (en) A method for generating induced pluripotent stem cells from mesenchymal stem cells using phlorotannin fractionation
IL273987A (en) Methods for diagnosing mesenchymal stem cells
SI3064574T1 (sl) Postopek za diferenciranje pluripotentne matične celice, inducirane iz mezenhimske matične celice, v hondrocit
EP3385368A4 (fr) Procédé de production de cellules souches mésenchymateuses
SG11201703600YA (en) Method of distinguishing mesenchymal stem cells
RS65645B1 (sr) Postupak za proizvodnju indukovanih pluripotentnih matičnih ćelija od adipoznih mezenhimalnih matičnih ćelija i indukovane pluripotentne matične ćelije proizvedene tim postupkom
HK1216260A1 (zh) 種臨床級胎盤間充質幹細胞製備方法
HK1254737A1 (zh) 幹細胞培養方法
SG10201800796XA (en) Method of distinguishing mesenchymal stem cells
AU2014903390A0 (en) A method for culturing mesenchymal stem cells